Literature DB >> 1555360

Intraosseous arterial architecture in nontraumatic avascular necrosis of the femoral head. Microangiographic and histologic study.

K Ohzono1, K Takaoka, S Saito, M Saito, M Matsui, K Ono.   

Abstract

To determine the vascular architecture of nontraumatic avascular necrosis of the femoral head (ANFH), 38 femoral heads procured from 31 ANFH patients were studied by microangiographic and histologic methods. Microangiography showed that the head was consistently stratified into three zones: the normal vascular, the reparative vascular, and the avascular. Microangiographic abnormalities were closely correlated with the histologic changes in each zone. The extent of the necrotic area proved to depend on the extent and number of involved intraosseous nutrient arteries. Circumscribed necrosis accompanied interruption of the lateral epiphyseal arteries in their intra-capital portion. Extensive necrosis resulted from multiple vascular involvement, which included not only the lateral epiphyseal arteries, but also the superior and inferior metaphyseal arteries. Histologic examination of different levels of the nutrient arteries revealed many intraosseous pathologic vascular changes in apposition to the ischemic episode of the femoral head. Interruption of the blood supply causing ANFH occurs in the intracapital arteries probably because of vascular wall damage, and the extent of necrosis depends on the number of the involved nutrient arteries and their proximity to the intracapital site of origin.

Entities:  

Mesh:

Year:  1992        PMID: 1555360

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  13 in total

1.  Repair in osteonecrosis of the femoral head: MR imaging features at long-term follow-up.

Authors:  Masaki Takao; Takashi Nishii; Takashi Sakai; Hideki Yoshikawa; Nobuhiko Sugano
Journal:  Clin Rheumatol       Date:  2010-03-16       Impact factor: 2.980

2.  Osteonecrosis of the femoral head extending into the femoral neck.

Authors:  Yuma Sakamoto; Takuaki Yamamoto; Goro Motomura; Akio Sakamoto; Ryosuke Yamaguchi; Kenyu Iwasaki; Garida Zhao; Kazuyuki Karasuyama; Yukihide Iwamoto
Journal:  Skeletal Radiol       Date:  2012-09-30       Impact factor: 2.199

3.  Pathophysiology and risk factors for osteonecrosis.

Authors:  Kalpit N Shah; Jennifer Racine; Lynne C Jones; Roy K Aaron
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

4.  Nitric oxide content and apoptosis rate in steroid-induced avascular necrosis of the femoral head.

Authors:  Rui Bai; Wanlin Liu; Aiqing Zhao; Zhengqun Zhao; Dianming Jiang
Journal:  Exp Ther Med       Date:  2015-05-26       Impact factor: 2.447

5.  Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head.

Authors:  Deike Varoga; Wolf Drescher; Melanie Pufe; Godo Groth; Thomas Pufe
Journal:  Clin Orthop Relat Res       Date:  2009-12       Impact factor: 4.176

6.  [Aseptic osteonecrosis in children and adolescents].

Authors:  E von Stillfried; M-A Weber
Journal:  Orthopade       Date:  2014-08       Impact factor: 1.087

7.  Osteonecrosis of Femoral Head Treated with Extracorporeal Shock Wave Therapy: Analysis of Short-term Clinical Outcomes of Treatment with Radiologic Staging.

Authors:  Jin-Young Lee; Jae-Woo Kwon; Jung-Seob Park; Kyeol Han; Woo-Jin Shin; Jeong-Gil Lee; Byung Hoon Lee
Journal:  Hip Pelvis       Date:  2015-12-30

8.  Porous Tantalum Implant in Treating Osteonecrosis of the Femoral Head: Still a Viable Option?

Authors:  Jinhui Ma; Wei Sun; Fuqiang Gao; Wanshou Guo; Yunting Wang; Zirong Li
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

9.  Clinical and Radiological Outcomes of Extracorporeal Shock Wave Therapy in Early-Stage Femoral Head Osteonecrosis.

Authors:  Abdulrahman D Algarni; Hassan M Al Moallem
Journal:  Adv Orthop       Date:  2018-08-19

10.  High-Energy Extracorporeal Shock Wave for Early Stage Osteonecrosis of the Femoral Head: A Single-Center Case Series.

Authors:  Fuqiang Gao; Wei Sun; Zirong Li; Wanshou Guo; Weiguo Wang; Liming Cheng; Bailiang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.